Login / Signup

Structure of the p53 degradation complex from HPV16.

John C K WangHannah T BaddockAmirhossein MafiIan T FoeMatthew BratkowskiTing-Yu LinZena D JensvoldMagdalena Preciado LópezDavid StokoeDan EatonQi HaoAaron H Nile
Published in: Nature communications (2024)
Human papillomavirus (HPV) is a significant contributor to the global cancer burden, and its carcinogenic activity is facilitated in part by the HPV early protein 6 (E6), which interacts with the E3-ligase E6AP, also known as UBE3A, to promote degradation of the tumor suppressor, p53. In this study, we present a single-particle cryoEM structure of the full-length E6AP protein in complex with HPV16 E6 (16E6) and p53, determined at a resolution of ~3.3 Å. Our structure reveals extensive protein-protein interactions between 16E6 and E6AP, explaining their picomolar binding affinity. These findings shed light on the molecular basis of the ternary complex, which has been pursued as a potential therapeutic target for HPV-driven cervical, anal, and oropharyngeal cancers over the last two decades. Understanding the structural and mechanistic underpinnings of this complex is crucial for developing effective therapies to combat HPV-induced cancers. Our findings may help to explain why previous attempts to disrupt this complex have failed to generate therapeutic modalities and suggest that current strategies should be reevaluated.
Keyphrases
  • high grade
  • protein protein
  • transcription factor
  • cervical cancer screening
  • small molecule
  • squamous cell carcinoma
  • oxidative stress
  • risk assessment
  • young adults
  • high glucose
  • diabetic rats
  • drug induced